Philip Noone's guest appearances

Philip Noone

The Architects Of Business

Business Matters with Karl Fitzpatrick

B2BInterviews.com

Brian Lee

Brody Sweeney

Liam Griffin

Dan Rogers

Justin Miller

John Jantsch

Conor Brady

Matt Porter

Paul Clarke

Chris Yeh

Brendan Kane

Bob Proctor

Tom Cronin

Margaret Heffernan

Mike Harris

OwlTail

 Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer nofollow" target="_blank">acast.com/privacy</a> for more information.

Philip Noone reveals how Aalto BioReagents is identifying & developing treatments for emerging viruses

Exclusive CEO Interview with Aalto Bio Reagents CEO Philip Noone.  Aalto Bio Reagents is a privately held biotech company based in Dublin.  The company has a significant product portfolio inclusive of a new COVID-19 Mab.

Exclusive CEO Interview with Aalto Bio Reagents CEO Philip Noone.  Aalto Bio Reagents is a privately held biotech company based in Dublin.  The company has a significant product portfolio inclusive of a new COVID-19 Mab.

Interview with Aalto Bio Reagents CEO Philip Noone 

Aalto Bio is amongst a number of companies working on a vaccine for COVID-19.The Dublin-based biotech company researches and develops proteins and reagents that are provided to pharmaceutical companies that in turn develop diagnostic tests for viruses.CEO of Aalto Bio, Philip Noone who has been working in the virus diagnostics space for twenty-five years, says his company has been working on the clinical trials with a couple of companies who are developing vaccines. They include the American pharma giant, Moderna.Noone told Sonya Lennon, host of The Architects of Business, made in partnership with EY Entrepreneur Of The Year™, about the pace at which the vaccine development is happening:"Moderna have done their phase two clinical trials. You do three phases of clinical trials before you bring the product to market. "They're in their third phase and they're probably moving at a speed faster than anybody else."So, we've been working hand in hand with them, helping them with their clinical trials in order to get a vaccine on the market faster. "He goes onto explain on the podcast why he thinks a vaccine will be available before the end of the year.

Aalto Bio is amongst a number of companies working on a vaccine for COVID-19. The Dublin-based biotech company researches and develops proteins and reagents that are provided to pharmaceutical companies that in turn develop diagnostic tests for viruses. CEO of Aalto Bio, Philip Noone who has been working in the virus diagnostics space for twenty-five years, says his company has been working on the clinical trials with a couple of companies who are developing vaccines. They include the American pharma giant, Moderna. Noone told Sonya Lennon, host of The Architects of Business, made in partnership with EY Entrepreneur Of The Year™, about the pace at which the vaccine development is happening: "Moderna have done their phase two clinical trials. You do three phases of clinical trials before you bring the product to market. "They're in their third phase and they're probably moving at a speed faster than anybody else. "So, we've been working hand in hand with them, helping them with their clinical trials in order to get a vaccine on the market faster. " He goes onto explain on the podcast why he thinks a vaccine will be available before the end of the year.

"End of the year is a best guess for a vaccine" - Philip Noone on the global race for COVID vaccine